Fullscript Acquisition of Rupa Health Ushers in New Era for Personalized Healthcare
Deal News | Jun 11, 2025 | EIN

In a transformative move within the healthcare industry, Fullscript, a leading platform in whole person care, announced its acquisition of Rupa Health on October 10, 2024. The merger aims to create a comprehensive clinical platform by integrating Fullscript's supplement dispensing capabilities with Rupa Health's lab test ordering services. Founded in 2011, Fullscript had been an influential provider of practitioner-grade supplements before the acquisition, serving over 100,000 healthcare providers and 10 million patients, focusing on evidence-based protocols. Meanwhile, Rupa Health, launched in 2020, streamlined diagnostic testing processes and educational services for integrative medicine practitioners. Prior to the merger, both companies operated in adjacent realms within the integrative healthcare space, with Fullscript concentrating on supplement protocols and Rupa Health on diagnostic testing. The acquisition represents a strategic expansion to leverage complementary strengths: Fullscript's established infrastructure and Rupa Health's testing logistics expertise. The unified platform is expected to enhance clinical efficiency and patient outcomes, reinforcing the movement toward whole person care in healthcare.
Sectors
- Healthcare Technology
- Integrative Medicine
Geography
- United States – Rupa Health and Fullscript, the main companies involved in the acquisition, operate primarily within the United States. The focus of the merger is to improve healthcare delivery across the country's integrative healthcare landscape.
Industry
- Healthcare Technology – The article discusses a merger between two companies focused on enhancing healthcare delivery through advanced technology platforms. Fullscript specializes in digital supplement dispensing, while Rupa Health focuses on lab test ordering technology.
- Integrative Medicine – Both companies operate within the integrative medicine sector, with Fullscript providing supplement protocols and Rupa Health streamlining lab diagnostics, aiming to deliver comprehensive whole-person care.
Financials
- – The article does not specify the financial terms of the acquisition between Fullscript and Rupa Health.
Participants
Name | Role | Type | Description |
---|---|---|---|
Fullscript | Acquirer | Company | A healthcare platform focused on supplement dispensing and personalized treatment planning, providing services to over 100,000 healthcare providers and 10 million patients. |
Rupa Health | Target Company | Company | A company specializing in lab test ordering systems, catering to integrative medicine practitioners by simplifying lab logistics. |
Kyle Braatz | CEO of Fullscript | Person | Co-founder and CEO of Fullscript, playing a key role in the strategic direction of the company. |
Tara Viswanathan | CEO of Rupa Health | Person | Co-founder and CEO, responsible for leading Rupa Health's growth in the integrative medicine space. |
Dr. Rob Kachko | User and Advocate of Fullscript | Person | A naturopathic doctor who has provided testimonials regarding the benefits of using Fullscript in clinical practice. |
Dr. Jeff Gladd | Chief Medical Officer at Fullscript | Person | Responsible for overseeing medical strategies at Fullscript. |
Dr. Cheng Ruan | Founder of the Texas Center for Lifestyle Medicine | Person | Supports the integration of Fullscript and is a proponent of personalized care improvements achieved through the merger. |